Bracco Diagnostics
ProHance (Gadoteridol) Injection, 279.3 mg/mL, For Pediatric Patients Younger Than Two Years Receives FDA Approval
ProHance was previously approved for this use in patient populations over the age of two.
Bracco Diagnostics